• 1 January 1976
    • journal article
    • research article
    • Vol. 31  (3) , 389-396
Abstract
Twelve preparations from mycobacterial cell walls and culture supernatant fluids were tested for their ability to activate lymphocytes from Balb/c or Nu/Nu mice and to increase the release of mediators from macrophages in vitro. The peptidoglycolipids (wax D) were B[bone marrow-derived]-cell mitogens and induced plaque-forming cells. These properties were lost if the glycopeptide component was removed, leaving the pure lipid, mycolic acid. Neither the glycopeptide fractions, with well-documented adjuvant properties, nor mycobacterial polysaccharide II-activated B cells. Only intact peptidoglycolipid showed synergy with the mitogenic effect of phytohemagglutinin (PHA) on thymocytes from Balb/c mice. The effect was much smaller than with Escherichia coli lipopolysaccharide (LPS) or dextran sulfate. The peptidoglycolipid also enhanced the release of factors from macrophages able to modify the response of Balb/c thymus cells to PHA. In this respect it resembled E. coli LPS. Adjuvant active glycopeptides did not share this property.